Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dueling Journal Commentaries Revisit FDA Approval of Abiomed's Impella

21 Mar 2016

Related Content

FDA Seeks PMA Requirements For More Pre-Amendment Devices

15 Aug 2011

<em>Impella 2.5 </em>PMA Gives Abiomed Big Growth Potential For High-Risk PCIs

24 Mar 2015

FDA Sets PMA Standard For AEDs, Giving Marketed Devices Time To Comply

28 Jan 2015

Abiomed Makes Its Case For <i>Impella</i> In High-Risk Angioplasty Cases

11 Apr 2011

FDA Orders Firms To Submit Data For 25 Pre-Amendment Device Types

13 Apr 2009

Additional Topics

Regulation Post Market Regulation & Studies Clinical Trials Approvals Safety Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.